Download PDF
CC BY 4.0 · Surg J (N Y) 2022; 08(02): e131-e135
DOI: 10.1055/s-0041-1740626
Original Article

Coexistence of Histologically Proven Chronic Lymphocytic Thyroiditis with Other Thyroid Disorders: A Retrospective Study

G. Gejoe 
1   General Surgery, Government Medical College, Trivandrum, Kerala, India
,
I.P. Yadev 
1   General Surgery, Government Medical College, Trivandrum, Kerala, India
,
Amrutha Kumaran
1   General Surgery, Government Medical College, Trivandrum, Kerala, India
,
K.S. Swasthik
1   General Surgery, Government Medical College, Trivandrum, Kerala, India
,
Meer M. Chisthi 
1   General Surgery, Government Medical College, Trivandrum, Kerala, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Hashimoto's thyroiditis (HT) is the commonest autoimmune thyroid pathology. It has been reported in increased numbers recently, probably due to the increase in autoimmune diseases across many parts of the world. It is sometimes found associated with other diseases as well as other diseases of the thyroid. There is an unproven association of this condition with thyroid cancer, particularly papillary thyroid carcinoma (PTC).

Methods This was a retrospective study performed over a period of 5 years. The objectives of this study were to find out the prevalence of histopathologically proven HT in surgically resected thyroid glands for various indications and its association with other thyroid disorders, especially thyroid malignancies. Total 4,630 patients who underwent thyroidectomy during the study period and met the criteria for inclusion were considered for analysis.

Results Histopathologically proven features of HT were present in 1,295 (28%) of the cases. Among these, 445 (34.36%) had only HT while 850 (65.66%) had HT along with other thyroid diseases. The most common disease associated with HT was multinodular goiter (44.2%), followed by PTC (15.2%). Patients with HT exhibited a higher rate of papillary cancer (16.7%) compared with patients without this pathology (13.8%). Statistically significant association between papillary cancer and HT was found among the female patients.

Conclusion The prevalence of HT in patients undergoing thyroidectomy is high in the studied population. A statistically significant association exists between papillary thyroid cancer and thyroiditis among female patients. This could form the basis for further research along these lines.

Keywords

Hashimoto's thyroiditis - papillary thyroid cancer - multinodular goiter - thyroid


Publication History

Received: 08 May 2021

Accepted: 09 November 2021

Article published online:
30 June 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI. et al. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens) 2010; 9 (04) 312-317
    CrossrefPubMedSearch in Google Scholar
  • 2 Usha Menon V, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc 2009; 107 (02) 72-77
    PubMedSearch in Google Scholar
  • 3 Cipolla C, Sandonato L, Graceffa G. et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005; 71 (10) 874-878
    CrossrefPubMedSearch in Google Scholar
  • 4 Jankovic B, Le KT, Hershman JM. Clinical review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?. J Clin Endocrinol Metab 2013; 98 (02) 474-482
    CrossrefPubMedSearch in Google Scholar
  • 5 Anderson L, Middleton WD, Teefey SA. et al. Hashimoto thyroiditis: Part 2, sonographic analysis of benign and malignant nodules in patients with diffuse Hashimoto thyroiditis. AJR Am J Roentgenol 2010; 195 (01) 216-222
    CrossrefPubMedSearch in Google Scholar
  • 6 Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. International J Celiac Disease 2015; 3: 151-155
    CrossrefPubMedSearch in Google Scholar
  • 7 McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine 2012; 42 (02) 252-265
    CrossrefPubMedSearch in Google Scholar
  • 8 Weetman AP. An update on the pathogenesis of Hashimoto's thyroiditis. J Endocrinol Invest 2021; 44 (05) 883-890
    CrossrefPubMedSearch in Google Scholar
  • 9 Weetman AP. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clin Endocrinol (Oxf) 2011; 74 (04) 411-418
    CrossrefPubMedSearch in Google Scholar
  • 10 Ruggeri RM, Trimarchi F, Giuffrida G. et al. Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence. Eur J Endocrinol 2017; 176 (02) 133-141
    CrossrefPubMedSearch in Google Scholar
  • 11 Ruggeri RM, Giuffrida G, Campennì A. Autoimmune endocrine diseases. Minerva Endocrinol 2018; 43 (03) 305-322
    CrossrefPubMedSearch in Google Scholar
  • 12 Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955; 70 (02) 291-297
    CrossrefPubMedSearch in Google Scholar
  • 13 Vita R, Ieni A, Tuccari G, Benvenga S. The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma. Rev Endocr Metab Disord 2018; 19 (04) 301-309
    CrossrefPubMedSearch in Google Scholar
  • 14 Liu Y, Li C, Zhao W, Wang Y. Hashimoto's thyroiditis is an important risk factor of papillary thyroid microcarcinoma in younger adults. Horm Metab Res 2017; 49 (10) 732-738
    Thieme ConnectPubMedSearch in Google Scholar
  • 15 Crile Jr G. Struma lymphomatosa and carcinoma of the thyroid. Surg Gynecol Obstet 1978; 147 (03) 350-352
    PubMedSearch in Google Scholar
  • 16 Holm L-E, Blomgren H, Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985; 312 (10) 601-604
    CrossrefPubMedSearch in Google Scholar
  • 17 Yoon Y-H, Kim HJ, Lee JW, Kim JM, Koo BS. The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol 2012; 269 (03) 1013-1017
    CrossrefPubMedSearch in Google Scholar
  • 18 Repplinger D, Bargren A, Zhang Y-W, Adler JT, Haymart M, Chen H. Is Hashimoto'S thyroiditis a risk factor for papillary thyroid cancer?. J Surg Res 2008; 144 (02) 228
    CrossrefPubMedSearch in Google Scholar
  • 19 Siriweera EH, Ratnatunga NVI. Profile of Hashimoto's thyroiditis in Sri Lankans: is there an increased risk of ancillary pathologies in Hashimoto's thyroiditis?. J Thyroid Res 2010; 2010 (Oct): 124264
    CrossrefPubMedSearch in Google Scholar
  • 20 Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, von Buchwald C. Association between Hashimoto's thyroiditis and thyroid cancer in 64,628 patients. Front Oncol 2017; 7: 53
    CrossrefPubMedSearch in Google Scholar
  • 21 Tamimi DM. The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 2002; 10 (02) 141-146
    CrossrefPubMedSearch in Google Scholar
  • 22 Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery 2009; 146 (06) 1099-1104
    CrossrefPubMedSearch in Google Scholar
  • 23 Larson SD, Jackson LN, Riall TS. et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 2007; 204 (05) 764-773 , discussion 773–775
    CrossrefPubMedSearch in Google Scholar
  • 24 Consorti F, Loponte M, Milazzo F, Potasso L, Antonaci A. Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res 2010; 45 (3-4): 333-337
    CrossrefPubMedSearch in Google Scholar
  • 25 Matesa-Anić D, Mateša N, Dabelić N, Kusić Z. Coexistence of papillary carcinoma and Hashimoto's thyroiditis. Acta Clin Croat 2009; 48 (01) 9-12
    PubMedSearch in Google Scholar
  • 26 Erdogan M, Erdem N, Cetinkalp S. et al. Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in Turkey. Endocrine 2009; 36 (03) 486-490
    CrossrefPubMedSearch in Google Scholar
  • 27 Wirtschafter A, Schmidt R, Rosen D. et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 1997; 107 (01) 95-100
    CrossrefPubMedSearch in Google Scholar
  • 28 Arif S, Blanes A, Diaz-Cano SJ. Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 2002; 41 (04) 357-362
    CrossrefPubMedSearch in Google Scholar
  • 29 Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE. Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?. Hum Pathol 2003; 34 (08) 764-769
    CrossrefPubMedSearch in Google Scholar
  • 30 Burstein DE, Nagi C, Wang BY, Unger P. Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 2004; 35 (04) 465-473
    CrossrefPubMedSearch in Google Scholar
  • 31 Mukasa K, Noh JY, Kunii Y. et al. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 2011; 21 (01) 37-41
    CrossrefPubMedSearch in Google Scholar
  • 32 Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR. Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 1995; 76 (11) 2312-2318
    CrossrefPubMedSearch in Google Scholar